R. Herber

464 total citations
27 papers, 396 citations indexed

About

R. Herber is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, R. Herber has authored 27 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Pharmacology and 6 papers in Pharmacology. Recurrent topics in R. Herber's work include Pharmacogenetics and Drug Metabolism (9 papers), Algal biology and biofuel production (6 papers) and Drug Transport and Resistance Mechanisms (4 papers). R. Herber is often cited by papers focused on Pharmacogenetics and Drug Metabolism (9 papers), Algal biology and biofuel production (6 papers) and Drug Transport and Resistance Mechanisms (4 papers). R. Herber collaborates with scholars based in France, Romania and Canada. R. Herber's co-authors include Gérard Siest, Jacques Magdalou, Roselyne Bidault, Corinne G. Jolivalt, Yves Christen, Brigitte Leininger‐Muller, Philìppe Bertrand, Luc Ferrari, Pierre Granger and Sylvie Fournel‐Gigleux and has published in prestigious journals such as FEBS Letters, Free Radical Biology and Medicine and Endocrinology.

In The Last Decade

R. Herber

26 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Herber France 13 153 112 65 64 58 27 396
Stanley R. Howell United States 11 151 1.0× 118 1.1× 46 0.7× 38 0.6× 20 0.3× 20 452
Dwight D. Stiff United States 13 158 1.0× 121 1.1× 69 1.1× 71 1.1× 17 0.3× 18 444
H. Bun France 14 180 1.2× 71 0.6× 64 1.0× 62 1.0× 60 1.0× 43 484
Ben J. van der Walt South Africa 14 150 1.0× 94 0.8× 53 0.8× 31 0.5× 22 0.4× 25 564
AndréE.M. McLean United Kingdom 10 116 0.8× 266 2.4× 96 1.5× 80 1.3× 9 0.2× 13 505
Joel Reinhardt United States 11 303 2.0× 41 0.4× 54 0.8× 14 0.2× 80 1.4× 17 636
Wang Cx China 8 110 0.7× 37 0.3× 46 0.7× 33 0.5× 30 0.5× 26 336
A. Strother United States 12 91 0.6× 108 1.0× 62 1.0× 50 0.8× 13 0.2× 28 433
Susan A. Janezic Canada 8 358 2.3× 142 1.3× 92 1.4× 51 0.8× 13 0.2× 10 627
George Lukas Switzerland 7 97 0.6× 64 0.6× 48 0.7× 22 0.3× 8 0.1× 12 445

Countries citing papers authored by R. Herber

Since Specialization
Citations

This map shows the geographic impact of R. Herber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Herber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Herber more than expected).

Fields of papers citing papers by R. Herber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Herber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Herber. The network helps show where R. Herber may publish in the future.

Co-authorship network of co-authors of R. Herber

This figure shows the co-authorship network connecting the top 25 collaborators of R. Herber. A scholar is included among the top collaborators of R. Herber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Herber. R. Herber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Enoiu, Milica, R. Herber, Pierre Leroy, & Maria Wellman. (2003). The role of gamma‐glutamyltranspeptidase in the metabolism and cytotoxicity of 4‐hydroxynonenal‐glutathione conjugate: Evidence and hypothesis. BioFactors. 17(1-4). 175–185. 2 indexed citations
2.
Enoiu, Milica, R. Herber, Robert Wennig, et al.. (2002). γ-Glutamyltranspeptidase-Dependent Metabolism of 4-Hydroxynonenal–Glutathione Conjugate. Archives of Biochemistry and Biophysics. 397(1). 18–27. 28 indexed citations
3.
Jolivalt, Corinne G., Brigitte Leininger‐Muller, Philìppe Bertrand, et al.. (2000). Differential oxidation of apolipoprotein E isoforms and interaction with phospholipids. Free Radical Biology and Medicine. 28(1). 129–140. 65 indexed citations
4.
Pless, Dorothy D., Jean-Noël Gouze, Claire Senay, et al.. (1999). Characterization of the UDP-Glucuronosyltransferases Involved in the Glucuronidation of An Antithrombotic Thioxyloside in Rat and Humans. Drug Metabolism and Disposition. 27(5). 588–595. 16 indexed citations
5.
Buronfosse, Thierry, et al.. (1998). Species-dependent enantioselective glucuronidation of carprofen. Xenobiotica. 28(6). 595–604. 17 indexed citations
6.
Herber, R., J. Van Cantfort, J. De Graeve, et al.. (1995). Reduction and glucuronidation of naftazone by human and rat liver microsomes.. Drug Metabolism and Disposition. 23(12). 1305–1314. 13 indexed citations
7.
Battaglia, Eric, Claire Senay, Sylvie Fournel‐Gigleux, et al.. (1994). The chemical modification of human liver UDP‐glucuronosyltransferase UGT1*6 reveals the involvement of a carboxyl group in catalysis. FEBS Letters. 346(2-3). 146–150. 29 indexed citations
8.
Ferrari, Luc, R. Herber, Anne‐Marie Batt, & Gérard Siest. (1993). Differential effects of human recombinant interleukin-1β and dexamethasone on hepatic drug-metabolizing enzymes in male and female rats. Biochemical Pharmacology. 45(11). 2269–2277. 32 indexed citations
9.
Ferrari, Luc, et al.. (1993). Interleukin-1 beta differentially represses drug-metabolizing enzymes in arthritic female rats.. Journal of Pharmacology and Experimental Therapeutics. 264(2). 1012–1020. 17 indexed citations
10.
Herber, R., et al.. (1992). Glucuronidation of 3′-azido-3′-deoxythymidine in human liver microsomes: enzyme inhibition by drugs and steroid hormones. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1139(1-2). 20–24. 24 indexed citations
11.
Magdalou, Jacques, R. Herber, Roselyne Bidault, & Gérard Siest. (1992). In vitro N-glucuronidation of a novel antiepileptic drug, lamotrigine, by human liver microsomes.. Journal of Pharmacology and Experimental Therapeutics. 260(3). 1166–1173. 67 indexed citations
12.
Herber, R., et al.. (1991). Identification of novel phencyclidine metabolites formed in vitro by rabbit microsomal metabolism. Xenobiotica. 21(11). 1493–1499. 2 indexed citations
13.
Strazielle, Nathalie, Muriel Totis, R. Herber, et al.. (1991). Effects of RP 52028 and phenobarbital on mRNA levels of inducible and constitutive sex-specific cytochrome P450 isozymes in rat liver. Biochemical Pharmacology. 42(5). 1053–1060. 3 indexed citations
15.
Herber, R., et al.. (1974). Occurrence of trans-phytoene in microorganisms grown in the absence of carotenogenesis inhibitors. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 348(3). 357–360. 4 indexed citations
16.
Granger, Pierre, et al.. (1973). 1H and 13C NMR spectra of cis and trans phytoene isomers. Journal of Magnetic Resonance (1969). 10(1). 43–50. 14 indexed citations
17.
Herber, R., et al.. (1972). [Demonstration of trans isomers of phytoene and phytofluene in Rhodopseudomonas spheroides, Rhodospirillum rubrum and Mucor hiemalis].. PubMed. 274(2). 327–9. 1 indexed citations
18.
Herber, R., et al.. (1972). Influence de différents composés chimiques sur la carotenogenèse de Mucor hiemalis. Phytochemistry. 11(12). 3461–3464. 7 indexed citations
19.
Herber, R., et al.. (1972). Action de differentes substances chimiques sur la carotenogenese de Rhodopseudomonas spheroides. Chemico-Biological Interactions. 5(5). 341–350. 2 indexed citations
20.
Herber, R., et al.. (1972). [Metabolism of some phenolic derivatives in Mucor hiemalis].. PubMed. 166(8). 1087–90. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026